Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.

Although most cases of chronic obstructive pulmonary disease (COPD) occur in smokers, only a fraction of smokers develop the disease. We hypothesized distinct molecular signatures for COPD and emphysema in the peripheral blood mononuclear cells (PBMCs) of current and former smokers. To test this hypothesis, we identified and validated PBMC gene expression profiles in smokers with and without COPD. We generated expression data on 136 subjects from the COPDGene study, using Affymetrix U133 2.0 microarrays (Affymetrix, Santa Clara, CA). Multiple linear regression with adjustment for covariates (gender, age, body mass index, family history, smoking status, and pack-years) was used to identify candidate genes, and ingenuity pathway analysis was used to identify candidate pathways. Candidate genes were validated in 149 subjects according to multiplex quantitative real-time polymerase chain reaction, which included 75 subjects not previously profiled. Pathways that were differentially expressed in subjects with COPD and emphysema included those that play a role in the immune system, inflammatory responses, and sphingolipid (ceramide) metabolism. Twenty-six of the 46 candidate genes (e.g., FOXP1, TCF7, and ASAH1) were validated in the independent cohort. Plasma metabolomics was used to identify a novel glycoceramide (galabiosylceramide) as a biomarker of emphysema, supporting the genomic association between acid ceramidase (ASAH1) and emphysema. COPD is a systemic disease whose gene expression signatures in PBMCs could serve as novel diagnostic or therapeutic targets.

[1]  Ian W. Dawes,et al.  Gene-expression profiling of peripheral blood mononuclear cells in sepsis* , 2009, Critical care medicine.

[2]  Stephen T Holgate,et al.  Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[3]  Steven Shapiro,et al.  Peripheral blood gene expression profiles in COPD subjects , 2011, Journal of Clinical Bioinformatics.

[4]  Laszlo Nagy,et al.  Chronic Obstructive Pulmonary Disease-Specific Gene Expression Signatures of Alveolar Macrophages as well as Peripheral Blood Monocytes Overlap and Correlate with Lung Function , 2011, Respiration.

[5]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[6]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[7]  R. Desnick,et al.  Molecular Cloning and Characterization of a Full-length Complementary DNA Encoding Human Acid Ceramidase , 1996, The Journal of Biological Chemistry.

[8]  Katherine P Andriole,et al.  Lung volumes and emphysema in smokers with interstitial lung abnormalities. , 2011, The New England journal of medicine.

[9]  K. Kariman,et al.  Pulmonary involvement in Fabry's disease. , 1978, The American journal of medicine.

[10]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[11]  R. B. Cary,et al.  Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells. , 2006, Toxicology.

[12]  H. Boezen,et al.  Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies , 2008, European Respiratory Journal.

[13]  J. Kleinjans,et al.  Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. , 2006, Carcinogenesis.

[14]  S. P. Nana-Sinkam,et al.  Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.

[15]  J. Epstein,et al.  Foxp1/2/4-NuRD Interactions Regulate Gene Expression and Epithelial Injury Response in the Lung via Regulation of Interleukin-6* , 2010, The Journal of Biological Chemistry.

[16]  Y. Hozumi,et al.  Immunohistochemical localization in human tissues of GPI-80, a novel glycosylphosphatidyl inositol-anchored protein that may regulate neutrophil extravasation , 2001, Cell and Tissue Research.

[17]  G. Washko,et al.  Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD , 2010, European Respiratory Journal.

[18]  X. Busquets,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[19]  Gordon K. Smyth,et al.  Technical Variability Is Greater than Biological Variability in a Microarray Experiment but Both Are Outweighed by Changes Induced by Stimulation , 2011, PloS one.

[20]  M. Lu,et al.  Foxp2 and Foxp1 cooperatively regulate lung and esophagus development , 2007, Development.

[21]  E. Piitulainen,et al.  Analysis of Systemic Biomarkers in COPD Patients , 2004, COPD.

[22]  Naftali Kaminski,et al.  Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Kleinjans,et al.  Differential gene expression in human peripheral blood mononuclear cells induced by cigarette smoke and its constituents. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  S. Stouffer.  Adjustment during army life , 1977 .

[25]  B. Celli,et al.  Gene expression profiling of human lung tissue from smokers with severe emphysema. , 2004, American journal of respiratory cell and molecular biology.

[26]  Dave Singh,et al.  COPD phenotype description using principal components analysis , 2009, Respiratory research.

[27]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[28]  M. Nyegaard,et al.  Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders , 2008, Thorax.

[29]  L. Obeid,et al.  Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. , 2008, Biochimica et biophysica acta.

[30]  A. Schols,et al.  Systemic effects in COPD. , 2002, Chest.

[31]  L. Trupin,et al.  Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease , 2005, Environmental health : a global access science source.

[32]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[34]  M. Scian,et al.  Gene expression profiling of peripheral blood leukocytes identifies potential novel biomarkers of chronic obstructive pulmonary disease in current and former smokers , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[35]  Michael N Sawka,et al.  Exertional heat injury and gene expression changes: a DNA microarray analysis study. , 2004, Journal of applied physiology.

[36]  E. Silverman,et al.  Genetics and genomics of chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.

[37]  J. Blangero,et al.  Diverse biological activities of the vascular non-inflammatory molecules - the Vanin pantetheinases. , 2012, Biochemical and biophysical research communications.

[38]  Anthony Bosco,et al.  Interactions between Innate Antiviral and Atopic Immunoinflammatory Pathways Precipitate and Sustain Asthma Exacerbations in Children1 , 2009, The Journal of Immunology.

[39]  C. Ballantyne,et al.  Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. , 2004, The Journal of clinical investigation.

[40]  D. DeMeo,et al.  Molecular biomarkers for quantitative and discrete COPD phenotypes. , 2009, American journal of respiratory cell and molecular biology.

[41]  C. Liew,et al.  The peripheral-blood transcriptome: new insights into disease and risk assessment. , 2007, Trends in molecular medicine.

[42]  L. Koenderman,et al.  Systemic inflammation in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[43]  M. Gladwin,et al.  Characterization of Whole Blood Gene Expression Profiles as a Sequel to Globin mRNA Reduction in Patients with Sickle Cell Disease , 2009, PloS one.

[44]  L. Almasy,et al.  Open Access Research Article Transcriptomic Epidemiology of Smoking: the Effect of Smoking on Gene Expression in Lymphocytes , 2022 .

[45]  E. Suchman,et al.  The American soldier: Adjustment during army life. (Studies in social psychology in World War II), Vol. 1 , 1949 .

[46]  K. Kostikas,et al.  Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. , 2012, Chest.

[47]  R. Bowler,et al.  Involvement of ceramide in cell death responses in the pulmonary circulation. , 2011, Proceedings of the American Thoracic Society.

[48]  P. Barnes,et al.  Inflammation, Oxidative Stress and Systemic Effects in Mild Chronic Obstructive Pulmonary Disease , 2007, International journal of immunopathology and pharmacology.

[49]  C. Eng,et al.  Pulmonary involvement in Fabry disease. , 1997, American journal of respiratory and critical care medicine.

[50]  H. Twigg,et al.  Sphingolipid-mediated Inhibition of Apoptotic Cell Clearance by Alveolar Macrophages* , 2010, The Journal of Biological Chemistry.

[51]  N. Hayward,et al.  Expression profiling identifies genes involved in emphysema severity , 2009, Respiratory research.

[52]  Malik Yousef,et al.  Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. , 2009, Cancer research.

[53]  George Stephanopoulos,et al.  Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells , 2004, Journal of Neuroimmunology.

[54]  G. Skrepnek,et al.  Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. , 2004, The American journal of managed care.

[55]  Janet S. Lee,et al.  The Influence of Radiographic Phenotype and Smoking Status on Peripheral Blood Biomarker Patterns in Chronic Obstructive Pulmonary Disease , 2009, PloS one.

[56]  Jay B. Varkey,et al.  Viral infections in patients with chronic obstructive pulmonary disease , 2008, Current opinion in pulmonary medicine.